Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Subject : covid-19 Subject : emotional engagement Subject : immunogenicity, vaccine Subject : influenza, human
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2022 Jul 22; Vol. 13, pp. 832924. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy.

  • Authors : Sugihara K; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan.; Wakiya R

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunogenicity, Vaccine*

  • Source: Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jul 01; Vol. 61 (13), pp. 1953-1958. Date of Electronic Publication: 2022 Apr 23.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants.

  • Authors : Seki Y; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.; Yoshihara Y

Subjects: Antibodies, Viral* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: Med (New York, N.Y.) [Med] 2022 Jun 10; Vol. 3 (6), pp. 406-421.e4. Date of Electronic Publication: 2022 Apr 26.Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.

  • Authors : Gilboa M; Infectious Disease Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Immunogenicity, Vaccine*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology ; COVID-19/COVID-19/COVID-19/*prevention & control SARS-CoV-2 variants

  • Source: The Journal of infectious diseases [J Infect Dis] 2022 Mar 02; Vol. 225 (5), pp. 785-792.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.

  • Authors : Shem-Tov N; Division of Hematology and Bone-Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Subjects: Hematopoietic Stem Cell Transplantation* ; Immunogenicity, Vaccine*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. 884-891. Date of Electronic Publication: 2021 Oct 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination.

  • Authors : Kurteva E; Laboratory of Clinical Immunology, Unversity Hospital 'St. Ivan Rilski', Akad. Ivan Geshov Blvd 15, 1431, Sofia, Bulgaria.; Department of Clinical Immunology, Medical University of Sofia, Sofia, Bulgaria.

Subjects: BNT162 Vaccine*; COVID-19/COVID-19/COVID-19/*prevention & control ; Immunity, Humoral/Immunity, Humoral/Immunity, Humoral/*immunology

  • Source: Rheumatology international [Rheumatol Int] 2022 Mar; Vol. 42 (3), pp. 449-456. Date of Electronic Publication: 2022 Jan 20.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals.

  • Authors : Uprichard SL; Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.; Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.

Subjects: Immunogenicity, Vaccine*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Viruses [Viruses] 2022 Feb 10; Vol. 14 (2). Date of Electronic Publication: 2022 Feb 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.

  • Authors : Citu IM; Department of Internal Medicine I, 'Victor Babes' University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.; Citu C

Subjects: Immunogenicity, Vaccine*; Ad26COVS1/Ad26COVS1/Ad26COVS1/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Viruses [Viruses] 2022 Feb 02; Vol. 14 (2). Date of Electronic Publication: 2022 Feb 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read More Add to Saved list
×
Academic Journal

Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study.

  • Authors : Ruggeri EM; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy.; Nelli F

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: ESMO open [ESMO Open] 2022 Feb; Vol. 7 (1), pp. 100350. Date of Electronic Publication: 2021 Nov 27.Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029

Record details

Read More Add to Saved list
×
Academic Journal

Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.

  • Authors : Romero-Olmedo AJ; Institute of Medical Microbiology and Hospital Hygiene, Philipps-University Marburg, Marburg, Germany.; Schulz AR

Subjects: Immunity, Cellular* ; Immunity, Humoral* ; Immunogenicity, Vaccine*

  • Source: Nature microbiology [Nat Microbiol] 2022 Feb; Vol. 7 (2), pp. 195-199. Date of Electronic Publication: 2022 Jan 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101674869 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×